Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer.
Dienstmann R, De Dosso S, Felip E, Tabernero J. Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer. Mol Oncol. 2012 Feb; 6(1):15-26.